Literature DB >> 6604129

Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

S C Meuer, J C Hodgdon, R E Hussey, J P Protentis, S F Schlossman, E L Reinherz.   

Abstract

Recent studies suggested that the clonally unique Ti epitopes defined by non-cross-reactive monoclonal antibodies might represent the variable regions of the antigen receptor. Here we determine whether such anti-Ti antibodies could trigger clonal T cell activation. Anticlonotypic monoclonal antibodies to the 49/43-kdalton heterodimer of a given clone or antibodies to the 20/25-kdalton membrane associated monomorphic T3 molecule selectively induce proliferation and IL-2 secretion when linked to a solid support. In contrast, anti-T4 and anti-T8 antibodies under the same conditions have no effect. In conclusion, these results imply that anticlonotypic antibody functions in a fashion analogous to antigen and further support the notion that the T3-Ti molecular complex represents the antigen receptor on human T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604129      PMCID: PMC2187112          DOI: 10.1084/jem.158.3.988

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  A monoclonal antibody blocking human T cell function.

Authors:  E L Reinherz; R E Hussey; S F Schlossman
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

5.  Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes.

Authors:  E L Reinherz; R E Hussey; K Fitzgerald; P Snow; C Terhorst; S F Schlossman
Journal:  Nature       Date:  1981-11-12       Impact factor: 49.962

6.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Surface structures involved in target recognition by human cytotoxic T lymphocytes.

Authors:  S C Meuer; R E Hussey; J C Hodgdon; T Hercend; S F Schlossman; E L Reinherz
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

8.  Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen.

Authors:  G F Burns; A W Boyd; P C Beverley
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.

Authors:  S C Meuer; R E Hussey; A C Penta; K A Fitzgerald; B M Stadler; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

10.  Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones.

Authors:  A J Infante; P D Infante; S Gillis; C G Fathman
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  105 in total

1.  Preparation of anti-T idiotype monoclonal antibody reacting with human T leukaemic cell lines and with a small percentage of peripheral T lymphocytes.

Authors:  T Takahashi; K Imai; T Sugiyama; T Sasaki; A Yachi
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Functional properties of human lamina propria T lymphocytes assessed with mitogenic monoclonal antibodies.

Authors:  L Qiao; G Schürmann; M Betzler; S C Meuer
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  The human T-cell receptor.

Authors:  O Acuto; M Fabbi; A Bensussan; C Milanese; T J Campen; H D Royer; E L Reinherz
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

4.  The T11 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells.

Authors:  A Alcover; M J Weiss; J F Daley; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Energy of adhesion of human T cells to adsorption layers of monoclonal antibodies measured by a film trapping technique.

Authors:  I B Ivanov; A Hadjiiski; N D Denkov; T D Gurkov; P A Kralchevsky; S Koyasu
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

6.  Role of monocytes in anti-CD3-induced T-cell DNA synthesis: effect of chloroquine and monensin on anti-CD3-induced human T-cell activation.

Authors:  B Vayuvegula; K Ohira; S Gollapudi; S Gupta
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

7.  Mitogen-induced genes are subject to multiple pathways of regulation in the initial stages of T-cell activation.

Authors:  S G Irving; C H June; P F Zipfel; U Siebenlist; K Kelly
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

9.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.

Authors:  L A Beltz; F Kierszenbaum; M B Sztein
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.